Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
230.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (5.53%)
Market Cap: £121.43m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Directors Shareholdings

21 Mar 2013 15:33

RNS Number : 5892A
Microgen PLC
21 March 2013
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

On 21 March 2013 David Sherriff, Chief Executive Officer of Microgen plc, and Philip Wood, Group Finance Director of Microgen plc, increased their respective shareholdings to 438,466 (previously 189,000 shares) and 142,246 (previously 60,000 shares) respectively.

Β 

The increase in both Mr Sherriff and Mr WoodÒ€ℒs shareholding is as a result of the exercise of a total of 927,561 share options with a total of 595,849 shares sold to cover tax and other costs arising on the exercise of share options.  The following tables provide further details of the notification for Mr Sherriff and Mr Wood.

Β 

Β 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(iii) -Β both (i) and (ii)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

DAVID SHERRIFF

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

DAVID SHERRIFF

EXERCISE OF SHARE OPTIONS AND PART SALE OF SHARES TO COVER EXERCISE COSTS AND TAX LIABILITY.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

718,381 SHARES

0.87%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

468,915 SHARES

Β 

Β 

0.57%

13.

Price per share or value of transaction

14.

Date and place of transaction

75,000 SHARES PURCHASED AT AN OPTION PRICE OF 42.5 PENCE.

100,000 SHARES PURCHASED AT AN OPTION PRICE OF 70.5 PENCE.

397,991 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

93,340 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

52,050 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

468,915 SHARES SOLD AT A PRICE OF 118 PENCE.

21 MARCH 2013, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

438,466 SHARES

0.53%

21 MARCH 2013

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 82,527,244

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC:Β 020 7496 8100

Β 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

Β 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(iii)Β - both (i) and (ii)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

PHILIP WOOD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

PHILIP WOOD

EXERCISE OF SHARE OPTIONS AND PART SALE OF SHARES TO COVER EXERCISE COSTS AND TAX LIABILITY.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

209,180 SHARES

0.25%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

126,934 SHARES

0.15%

13.

Price per share or value of transaction

14.

Date and place of transaction

93,340 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

70,005 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

45,835 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

126,934 SHARES SOLD AT 118 PENCE

21 MARCH 2013, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

142,246 SHARES

0.17%

21 MARCH 2013

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 82,527,244

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC: 020 7496 8100

Β 

Β 

Β 

Name and signature of duly authorised officer of issuer responsible for making notification

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC

Date of notification: 21 MARCH 2013

www.microgen.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSEFLFLXXFXBBB
Date   Source Headline
3rd Mar 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:01 amRNSBoard Transition
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:43 amRNSTotal Voting Rights
31st Jan 20255:39 pmRNSNotification of Major Holdings
30th Jan 20254:58 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 202510:41 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 202510:47 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202410:06 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.